Wilson’s Syndrome is named for the doctor who discovered it: Denis Wilson. This condition is a thyroid syndrome that fails to show up on the conventional Thyroid Test used to detect hypothyroidism. As a result, the American Thyroid Association has unfairly announced that because the syndrome can’t be found in traditional ways, there’s not enough evidence to show it exists. The hundreds of thousands of men and women who have been diagnosed with the disease and have successfully recovered by using its two primary treatments can dispute this.
Wilson’s Syndrome is characterized by abnormally low body temperature, heat/cold intolerance, fatigue, and many other symptoms typically found in a patient who has hypothyroidism. Because of its association with low body temperature, the disease is sometimes called Wilson’s Temperature Syndrome.
Due to setbacks in funding, not enough research is being done to establish a thorough medical documentation of this serious thyroid syndrome. The American Thyroid Association notes this lack of research. It is vital that in the years to come, more doctors, pharmaceutical companies and scientists work to enlarge the body of knowledge about Wilson’s Syndrome. Awareness of the disease is critical to enable doctors to treat the millions of people who continue to suffer because they are undiagnosed and untreated.
The most disheartening fact is that Wilson’s Syndrome can easily be treated with the administration of T3 (T3 protocol treatment) and a blend of herbs and minerals discovered by Dr. Michael Friedman. These relatively inexpensive treatments have helped Dr. Wilson and Dr. Friedman relieve the symptoms of the Wilson Syndrome in hundreds of thousands of patients, and they are currently available to people who suffer from the disorder.
Don’t dismiss symptoms of a thyroid condition simple because a THS test comes back negative. If you have symptoms, get treated for Wilson’s Syndrome. It might just give you back the quality of life you’ve lost since symptoms first appeared.
Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.
You must be logged in to post a comment.